Alosetron for irritable bowel syndrome - Reply

AW Mangel

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Alosetron for irritable bowel syndrome - Reply

Mangel, AW. (2000). Alosetron for irritable bowel syndrome - Reply. Lancet, 356(9246), 2009-2010.

Copy citation

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders

Alosetron for irritable bowel syndrome - Reply

Publications Info

Allen W. Mangel

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders

Article

Grandi Byen-supporting child growth and development through integrated, responsive parenting, nutrition and hygiene

Article

Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions

Article

"Show Me the Energy Costs"

Alosetron for irritable bowel syndrome - Reply

Publications Info

Meet the Experts

Allen W. Mangel

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders

Article

Grandi Byen-supporting child growth and development through integrated, responsive parenting, nutrition and hygiene

Article

Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions

Article

"Show Me the Energy Costs"